Welcome to our dedicated page for Justera Health news (Ticker: SCRSF), a resource for investors and traders seeking the latest updates and insights on Justera Health stock.
Justera Health Ltd. reports corporate and operating developments for a Canadian health and wellness company. Its updates cover personalized healthcare services, IV vitamin therapy, Naturevan Nutrition nutritional supplements, Juillet Wellness spa and wellness services, Vancouver retail activity, and Port North solventless cannabis products. Recurring announcements also address board and executive appointments, auditor changes, fiscal-year and reporting matters, restricted share unit grants, material agreements, capital-structure disclosures, and operating results.
Justera Health (OTC:SCRSF) appointed Bruce (Hwan) Lee as Chief Financial Officer, effective April 21, 2026, filling the vacancy after former CFO Paul Haber resigned March 2, 2026.
The company said Mr. Lee brings over two decades of finance experience across technology, education, healthcare and automobile sectors, with recent controller roles focusing on system implementation, automation and policy development to strengthen reporting, internal controls and corporate finance leadership.
Justera Health (OTC:SCRSF) appointed Andrew Ryu as Interim CEO and Chairman and added Ian (Ingoo) Kim to the board, effective March 12, 2026. The company says it will work toward resuming trading of its common shares on the CSE and will provide updates on progress.
The appointments are presented as steps to restore momentum, strengthen governance, and pursue opportunities in the Canadian health and wellness sector.
Justera Health Ltd. (OTC PINK:SCRSF) entered a definitive share and asset purchase agreement to sell its wholly owned subsidiary Port North Extracts Inc. on February 26, 2026. The purchaser will pay $1 and assume all of Port North's indebtedness and liabilities, subject to customary closing conditions.
The company also announced the resignations of CEO and director Joshua Herman and CFO Paul Haber, leaving Young Cho Lee as the sole remaining director and officer.
Justera Health (OTC:SCRSF) announced a change in its external auditors from SHIM & Associates LLP to Horizon Assurance LLP, effective August 7, 2025. The former auditor resigned on June 2, 2025. Due to this transition, the company's audited annual financial statements, originally due July 30, 2025, have been delayed.
The company confirmed there were no modified opinions in the former auditor's reports for the two most recent financial years. The change was approved by both the board of directors and audit committee, with no reportable events occurring during the former auditor's tenure. Required documentation has been filed on SEDAR in accordance with National Instrument 51-102.
Justera Health announced two significant corporate changes. First, the company reported the resignation of Richard Yoon from its Board of Directors, effective March 28, 2025. Yoon stepped down to pursue other professional opportunities.
The Board will continue under the leadership of Joshua Herman and Young Cho Lee, who remain committed to advancing the company's strategic initiatives and optimizing its asset portfolio value.
Additionally, Justera has modified its fiscal year end from December 31 to March 31. This change aims to better align the company's reporting cycle with its operational and strategic planning objectives.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has signed a non-binding LOI to acquire 100% of Babbage Mining Co., a proof-of-stake mining operation with Coinbase custodian accounts. The proposed transaction involves issuing 12,000,000 common shares at $0.02 per share, with a 1% royalty, subject to regulatory approvals.
The acquisition will enable Justera to accept cryptocurrencies like Bitcoin, Ethereum, and Solana as payment methods. The transaction is arm's length and won't constitute a fundamental change. The consideration shares may be subject to a 4-month hold period. The deal completion depends on corporate and regulatory approvals and entering into a definitive agreement.
Justera Health, which operates in healthcare, pharmaceuticals, and wellness sectors, recently expanded into cannabis through the Port North brand acquisition.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has announced a revision to the vesting schedule of Restricted Share Units (RSUs) granted on November 8, 2024, to comply with CSE policy 6.1(4). Under the new vesting schedule, 50% of RSUs will vest on March 9, 2025 (four months plus one day from issuance), and the remaining 50% will vest on May 8, 2025 (six months from issuance).
Port North, a subsidiary of Justera Health, has expanded operations by partnering with Lune Rise Farms in South Bruce County, Ontario. The collaboration aims to enhance production of premium solventless cannabis products for recreational and therapeutic markets. Lune Rise Farms specializes in sun-grown cultivars and premium fresh frozen products, while Port North is known for its proprietary solventless extraction methods. The partnership will support the expansion of Port North's product line, which includes Hand Rolled Ice Water Hash, Strain-Specific Full-Spectrum Gummies, and Full-Spectrum Live Rosin Vapes.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announces leadership changes as Young Cho Lee steps down as CEO effective November 15, 2024. The company's Director, Joshua Herman, has been appointed as the new Chief Executive Officer. Herman, bringing extensive public company experience, will focus on driving the company's growth and delivering value to stakeholders.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) announced the approval of 23 million restricted share units (RSUs) under its omnibus incentive plan. The RSUs, granted to employees, directors, and consultants, will vest in three stages: 50% immediately, 25% after three months, and the remaining 25% after six months from issuance. This initiative aims to retain skilled personnel and align their interests with shareholders.